Destroy, what destroys you

References

• Lee SW, Croft M. 4-1BB as a therapeutic target for human disease. Ther Targets Tnf Superfamily. 2009;647:120–4.
   Google Scholar
• Wang S, Chen L. Immunobiology of cancer therapies targeting CD137 and B7-H1/PD-1 cosignal pathways. Curr Top Microbiol Immunol. 2011;344:245–267. doi:10.1007/82_2010_81.
   PubMed Web of Science ®Google Scholar
• Chester C, Sanmamed MF, Wang J, Melero I. Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies. Blood. 2018;131:49–57. doi:10.1182/blood-2017-06-741041.
   PubMed Web of Science ®Google Scholar
• Wolfl M, Kuball J, Ho WY, Nguyen H, Manley TJ, Bleakley M, Greenberg PD. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood. 2007;110:201–210. doi:10.1182/blood-2006-11-056168.
   PubMed Web of Science ®Google Scholar
• Wortzman ME, Clouthier DL, McPherson AJ, Lin GH, Watts TH. The contextual role of TNFR family members in CD8(+) T-cell control of viral infections. Immunol Rev. 2013;255:125–148. doi:10.1111/imr.12086.
   PubMed Web of Science ®Google Scholar
• Sanchez-Paulete AR, Labiano S, Rodriguez-Ruiz ME, Azpilikueta A, Etxeberria I, Bolanos E, Lang V, Rodriguez M, Aznar MA, Jure-Kunkel M, et al. Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy. Eur J Immunol. 2016;46:513–522. doi:10.1002/eji.v46.3.
   PubMed Web of Science ®Google Scholar
• Dharmadhikari B, Wu M, Abdullah NS, Rajendran S, Ishak ND, Nickles E, Harfuddin Z, Schwarz H. CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses. Oncoimmunol. 2016;5:e1113367. doi:10.1080/2162402X.2015.1113367.
   PubMed Web of Science ®Google Scholar
• Alosaimi MF, Hoenig M, Jaber F, Platt CD, Jones J, Wallace J, Debatin KM, Schulz A, Jacobsen E, Moller P, et al. Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency. J Allergy Clin Immunol. 2019;144:574–583. doi:10.1016/j.jaci.2019.03.002.
   PubMed Web of Science ®Google Scholar
• Somekh I, Thian M, Medgyesi D, Gulez N, Magg T, Gallon Duque A, Stauber T, Lev A, Genel F, Unal E, et al. CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis. Blood. 2019. doi:10.1182/blood.2019000644.
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Fournier B, Cordeiro DJ, Winter S, Izawa K, Martin E, Boutboul D, Lenoir C, Fraitag S, Kracker S, et al. Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells. J Exp Med. 2019.
   Web of Science ®Google Scholar
• Pauly S, Broll K, Wittmann M, Giegerich G, Schwarz H. CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers. J Leukoc Biol. 2002;72:35–42.
   PubMed Web of Science ®Google Scholar
• Alfaro C, Echeveste JI, Rodriguez-Ruiz ME, Solorzano JL, Perez-Gracia JL, Idoate MA, Lopez-Picazo JM, Sanchez-Paulete AR, Labiano S, Rouzaut A, et al. Functional expression of CD137 (4-1BB) on T helper follicular cells. Oncoimmunol. 2015;4:e1054597. doi:10.1080/2162402X.2015.1054597.
   PubMed Web of Science ®Google Scholar
• Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunol Rev. 2019;291:174–189. doi:10.1111/imr.v291.1.
   PubMed Web of Science ®Google Scholar
• Yoshimori M, Imadome K, Komatsu H, Wang L, Saitoh Y, Yamaoka S, Fukuda T, Kurata M, Koyama T, Shimizu N, et al. CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals. PLoS One. 2014;9:e112564. doi:10.1371/journal.pone.0112564.
   PubMed Web of Science ®Google Scholar
• Priya Aravinth S, Rajendran S, Li Y, Wu M, Yi Wong AH, Schwarz H. Epstein-Barr virus-encoded LMP1 induces ectopic CD137 expression on and Reed-Sternberg cells via the PI3K-AKT-mTOR pathway. Leuk Lymph. 2019;6:1–8. doi:10.1080/10428194.2019.1607330.
   Google Scholar
• Ho WT, Pang WL, Chong SM, Castella A, Al-Salam S, Tan TE, Moh MC, Koh LK, Gan SU, Cheng CK, et al. Expression of CD137 on Hodgkin and Reed-Sternberg cells inhibits T-cell activation by eliminating CD137 ligand expression. Cancer Res. 2013;73:652–661. doi:10.1158/0008-5472.CAN-12-3849.
   PubMed Web of Science ®Google Scholar
• Anderson MW, Zhao S, Freud AG, Czerwinski DK, Kohrt H, Alizadeh AA, Houot R, Azambuja D, Biasoli I, Morais JC, et al. CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications. Am J Pathol. 2012;181:795–803. doi:10.1016/j.ajpath.2012.05.015.
   PubMed Web of Science ®Google Scholar
• Wu M, Wong HY, Lin JL, Moliner A, Schwarz H. Induction of CD137 expression by viral genes reduces T cell costimulation. J Cell Physiol. 2019;234:21076–21088. doi:10.1002/jcp.v234.11.
   PubMed Web of Science ®Google Scholar
• Shao Z, Harfuddin Z, Pang WL, Nickles E, Koh LK, Schwarz H. Trogocytic CD137 transfer causes an internalization of CD137 ligand on murine APCs leading to reduced T cell costimulation. J Leukoc Biol. 2015;97:909–919. doi:10.1189/jlb.3A0213-079RRR.
   PubMed Web of Science ®Google Scholar
• Rajendran S, Ho WT, Schwarz H. CD137 signaling in Hodgkin and Reed-Sternberg cell lines induces IL-13 secretion, immune deviation and enhanced growth. Oncoimmunol. 2016;5:e1160188. doi:10.1080/2162402X.2016.1160188.
   PubMed Web of Science ®Google Scholar
• Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Sem Cancer Biol. 2008;18:397–408. doi:10.1016/j.semcancer.2008.10.008.
   PubMed Web of Science ®Google Scholar
• Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, Zielinski C, Lutter D, Hoser J, Hastreiter M, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065–2080. doi:10.1084/jem.20160248.
   PubMed Web of Science ®Google Scholar
• Michel J, Langstein J, Hofstadter F, Schwarz H. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur J Immunol. 1998;28:290–295. doi:10.1002/(ISSN)1521-4141.
   PubMed Web of Science ®Google Scholar
• Shao Z, Sun F, Koh DR, Schwarz H. Characterisation of soluble murine CD137 and its association with systemic lupus. Mol Immunol. 2008;45:3990–3999. doi:10.1016/j.molimm.2008.05.028.
   PubMed Web of Science ®Google Scholar
• Labiano S, Palazon A, Bolanos E, Azpilikueta A, Sanchez-Paulete AR, Morales-Kastresana A, Quetglas JI, Perez-Gracia JL, Gurpide A, Rodriguez-Ruiz M, et al. Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism. Oncoimmunol. 2016;5:e1062967. doi:10.1080/2162402X.2015.1062967.
   PubMed Web of Science ®Google Scholar
• Furtner M, Straub RH, Kruger S, Schwarz H. Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia. Leukemia. 2005;19:883–885. doi:10.1038/sj.leu.2403675.
   PubMed Web of Science ®Google Scholar
• Kachapati K, Bednar KJ, Adams DE, Wu Y, Mittler RS, Jordan MB, Hinerman JM, Herr AB, Ridgway WM. Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice. J Autoimm. 2013;47:94–103. doi:10.1016/j.jaut.2013.09.002.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, Kang B, Liu Z, Jin L, Xing R, et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24:978–985. doi:10.1038/s41591-018-0045-3.
   PubMed Web of Science ®Google Scholar
• Shao Z, Schwarz H. CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J Leuko Biol. 2011;89:21–29. doi:10.1189/jlb.0510315.
   PubMed Web of Science ®Google Scholar
• Jiang D, Yue PS, Drenkard D, Schwarz H. Induction of proliferation and monocytic differentiation of human CD34+ cells by CD137 ligand signaling. Stem Cells. 2008;26:2372–2381. doi:10.1634/stemcells.2008-0158.
   PubMed Web of Science ®Google Scholar